News for USANA Health Sciences, Inc. (USNA)

On June 9, 2025, John Fleming, a Director at Usana Health Sciences Inc (USNA), sold 500 shares of the company, according to a SEC Filing. Following this transac

PR NewswireSALT LAKE CITY, June 2, 2025 SALT LAKE CITY, June 2, 2025 /PRNewswire/ -- Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE: USNA),

On May 27, 2025, Walter Noot, the Chief Operating Officer of Usana Health Sciences Inc, sold 6,291 shares of the company, as reported in a SEC Filing. Following

On May 9, 2025, G Iiekking, the Chief Financial Officer of Usana Health Sciences Inc (USNA), executed a sale of 4,548 shares of the company. Following this tran

PR NewswireSALT LAKE CITY, May 1, 2025 SALT LAKE CITY, May 1, 2025 /PRNewswire/ -- Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA) an

PR NewswireSALT LAKE CITY, April 28, 2025 SALT LAKE CITY, April 28, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition

USANA Health Sciences (USNA) Celavive Postbiotic Rescue Serum wins Good Housekeeping 2025 Beauty Award. The serum is designed for stressed and blemish-p

Read on to know what CXOs of global corporations are saying about India and their perspectives and plans during this earnings season

Consolidated Net Sales Growth: 12% year over year in constant currency.Mainland China Net Sales Growth: 6% sequential growth in the first quarter.Mainland Chin

Apr 23, 2025 / 03:00PM GMTOperator Greetings. Welcome to the USANA Health Sciences first quarter conference call. At this time, all participants are in a listen

Second consecutive year USANA won gold award in Natural Food Supplements category

USANA Health Sciences, Inc. (NYSE:USNA) Q1 2025 Earnings Conference Call April 23, 2025 11:00 AM ETCompany ParticipantsAndrew Masuda - Director, Investor...

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Qua

USANA Health Sciences, Inc. (USNA) reported a notable increase in revenue for the first quarter, achieving $250 million compared to $228 million in the same per

USANA Health Sciences, Inc. (USNA) reported Q1 2025 net sales of $250 million, marking a 10% year-over-year increase. Net earnings for the quarter fell

PR NewswireSALT LAKE CITY, April 14, 2025 SALT LAKE CITY, April 14, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition

Usana Health Sciences, Inc. (USNA) has released findings from a recent clinical study evaluating its Celavive Resurfacing Serum. The study focused on the serum'

RoboMarkets has announced the addition of more than 1,160 new assets to its R StocksTrader platform, strengthening its position as a regulated multi-asset

On March 3, 2025, Jim Brown, CEO & President of Usana Health Sciences Inc, sold 5,000 shares of the company, according to a SEC Filing. Following this transacti